Contact Information
1005 West Market St Suite 8, Athens, Alabama 35613, United States
Detailed Information
Pathway Healthcare
-
Services:
- Female
- Male
- HIV testing
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- Contingency management/motivational incentives
- Motivational interviewing
- Telemedicine/telehealth therapy
- Anger management
- Substance use disorder counseling
- Relapse prevention
- Trauma-related counseling
- Cognitive behavioral therapy
- Brief intervention
- Treatment for other addiction disorder
- Treatment for gambling disorder
- This facility administers/prescribes medication for alcohol use disorder
- Disulfiram
- Clonidine
- Nicotine replacement
- Medication for mental disorders
- Buprenorphine (extended-release, injectable)
- Lofexidine
- Non-nicotine smoking/tobacco cessation
- Naltrexone (oral)
- Acamprosate (CampralĀ®)
- Medications for Hepatitis C treatment
- Buprenorphine with naloxone
- Naltrexone (extended-release, injectable)
- Mental health services
- Transportation assistance
- Case management service
- Suicide prevention services
- Young Adults
- Adults
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Individual counseling
- Group counseling
- Smoking/vaping/tobacco cessation counseling
- Marital/couples counseling
- Family counseling
- Assistance with obtaining social services
- Housing services
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient
- Private for-profit organization
- In-network prescribing entity
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Medicare
- Cash or self-payment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- The Joint Commission
- State department of health
- Smoking permitted in designated area
- Screening for mental disorders
- Comprehensive mental health assessment
- Screening for tobacco use
- Complete medical history/physical exam
- Screening for substance use
- Comprehensive substance use assessment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Prescribes naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Vaping permitted in designated area
- Aftercare/continuing care
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
Gender Accepted
Testing
Treatment Approaches
Other Services
Type of Alcohol Use Disorder Treatment
Pharmacotherapies
Ancillary Services
Age Groups Accepted
Education and Counseling Services
Recovery Support Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Operation (e.g., Private, Public)
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Opioid Medications used in Treatment
License/Certification/Accreditation
Facility Smoking Policy
Assessment/Pre-treatment
Type of Care
Type of Opioid Treatment
Facility Vaping Policy
Transitional Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm